StockWatch
·
HomeLiveReports
Pharmaceuticals
Quarterly Result3 Nov 2026, 05:23 pm

Amanta Healthcare Approves Unaudited Financial Results for H1 FY27

AI Summary

Amanta Healthcare Limited's Board of Directors met on November 3, 2026, to approve the unaudited financial results for the quarter and half-year ended September 30, 2026. The Board also approved the Limited Review Report from the auditors, Price Waterhouse Chartered Accountants LLP, which provided an unmodified opinion. The meeting commenced at 4:00 PM and concluded at 5:00 PM.

Key Highlights

  • Board approved unaudited financial results for Q2 and H1 FY27.
  • Results pertain to the period ending September 30, 2026.
  • Auditors issued an unmodified Limited Review Report.
  • Meeting held on November 3, 2026.
View BSE Filing
AMANTA
Pharmaceuticals
Amanta Healthcare Ltd

Price Impact

More from AMANTA

Quarterly Result1h ago

Amanta Healthcare Q2FY27 Revenue Up 17.3% to ₹83.13 Cr

Regulatory1d ago, 5:42 pm

Amanta Healthcare: No Deviation in IPO Fund Utilization for Q3 FY27

Board Meeting1d ago, 5:33 pm

Amanta Healthcare Approves Unaudited Financial Results for Q2 FY27

More in Quarterly Result

SANGAMIND21m ago

Sangam India Ltd Declares Unaudited Financial Results for Q2 FY27

GGDPROP23m ago

G. G. Dandekar Properties Declares Un-audited Financial Results

MARIS23m ago

Maris Spinners Declares Unaudited Financial Results for Q2 FY27